Trials / Completed
CompletedNCT02428998
Safety for 24 Weeks Intake of Korean Red Ginseng in Adults
Safety Evaluation for 24 Weeks Intake of Korean Red Ginseng in Adults: A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Exploratory Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (actual)
- Sponsor
- Korea Ginseng Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Korean Red Ginseng appears to adverse events in adults taking 24 weeks Placebo and comparative assessment. And exploratory as Korean Red Ginseng blood sugar control, reduce body fat, URTI prevention, cardiovascular risk, renal function, cholesterol, improve, fatigue, and determine the impact on biological age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Korean Red Ginseng | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-08-01
- Completion
- 2017-04-01
- First posted
- 2015-04-29
- Last updated
- 2017-08-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02428998. Inclusion in this directory is not an endorsement.